Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · IEX Real-Time Price · USD
23.08
-0.14 (-0.60%)
At close: Jul 19, 2024, 4:00 PM
23.10
+0.02 (0.09%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Syndax Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
184
Market Cap
1.96B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 0 | - | - |
Dec 31, 2022 | 0 | - | - |
Dec 31, 2021 | 139.71M | 138.19M | 9,109.56% |
Dec 31, 2020 | 1.52M | - | - |
Dec 31, 2019 | 1.52M | - | - |
Dec 31, 2018 | 1.52M | -591.00K | -28.04% |
Dec 31, 2017 | 2.11M | 888.00K | 72.79% |
Dec 31, 2016 | 1.22M | 593.00K | 94.58% |
Dec 31, 2015 | 627.00K | - | - |
Dec 31, 2014 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Alignment Healthcare | 2.01B |
Novavax | 996.61M |
Amphastar Pharmaceuticals | 676.21M |
10x Genomics | 625.45M |
NovoCure | 525.66M |
Immunocore Holdings | 264.25M |
LeMaitre Vascular | 199.89M |
Arvinas | 71.30M |
SNDX News
- 16 days ago - Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire
- 5 weeks ago - Syndax Presents Updated Positive Data from BEAT AML and AUGMENT-102 Phase 1/2 Combination Trials of Revumenib in Patients with Acute Leukemias at EHA 2024 Congress - PRNewsWire
- 6 weeks ago - Syndax Announces Plans to Advance into Phase 1b Portion of Trial Evaluating Revumenib in Relapsed or Refractory Metastatic MSS CRC - PRNewsWire
- 6 weeks ago - Syndax Announces Participation at the Goldman Sachs 45th Annual Global Healthcare Conference - PRNewsWire
- 2 months ago - Syndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D. to the Board of Directors - PRNewsWire
- 2 months ago - Syndax Announces Participation at the Bank of America Securities 2024 Health Care Conference - PRNewsWire
- 2 months ago - Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update - PRNewsWire
- 2 months ago - Syndax to Announce First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 8, 2024 - PRNewsWire